Parliamentary questions

Questions

TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work

Browse the questions

Clear

Showing questions asked by Ken O'Flynn under the heading Health Services.

407 questions match, newest first.

Ken O'Flynn Written 27 May 2026 · to Health
264. Deputy Ken O'Flynn asked the Minister for Health whether any internal analysis has been conducted comparing treatment abroad scheme referral rates per capita across HSE health regions. [40621/26]
Ken O'Flynn Written 27 May 2026 · to Health
265. Deputy Ken O'Flynn asked the Minister for Health whether any equality impact assessment or access equity review has been conducted in relation to regional variation in treatment abroad scheme utilisation. [40622/26]
Ken O'Flynn Written 27 May 2026 · to Health
266. Deputy Ken O'Flynn asked the Minister for Health the dates and titles of all Internal Audit Office or Comptroller and Auditor General audits relating to the treatment abroad scheme since 2020. [40623/26]
Ken O'Flynn Written 27 May 2026 · to Health
267. Deputy Ken O'Flynn asked the Minister for Health whether any approval-rate benchmarking exists between specialties, consultants or regions under the treatment abroad scheme. [40624/26]
Ken O'Flynn Written 27 May 2026 · to Health
268. Deputy Ken O'Flynn asked the Minister for Health which officer or division holds responsibility for monitoring consistency of treatment abroad scheme decision-making nationally. [40625/26]
Ken O'Flynn Written 26 May 2026 · to Health
1157. Deputy Ken O'Flynn asked the Minister for Health if her Department maintains a central register identifying all statutory, non-statutory, intermediary-funded, and externally governed bodies receiving funding from the Department or the HSE; and if not, whether such a register will be established. [38919/26]
Ken O'Flynn Written 26 May 2026 · to Health
1158. Deputy Ken O'Flynn asked the Minister for Health whether any formal criteria or classification methodology is used by the Department or the HSE to determine whether a publicly funded organisation is categorised as statutory, non-statutory, voluntary, intermediary-funded, or publicly controlled for governance purposes; and if so, to provide details. [38920/26]
Ken O'Flynn Written 26 May 2026 · to Health
1159. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any mapping exercise since 2020 identifying which publicly funded health-related bodies are subject to the Code of Practice for the Governance of State Bodies, the Charities Governance Code, service-level agreements, or alternative governance frameworks; and if so, to provide details. [38921/26]
Ken O'Flynn Written 26 May 2026 · to Health
1160. Deputy Ken O'Flynn asked the Minister for Health whether any publicly funded health-sector bodies classified by the Central Statistics Office as public bodies are legally independent companies limited by guarantee; the number identified; and the aggregate level of State funding provided to such bodies in each year since 2020. [38922/26]
Ken O'Flynn Written 26 May 2026 · to Health
1161. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted any governance risk assessment regarding publicly funded bodies that are legally independent of the State but depend primarily on Exchequer funding; and if so, to provide details. [38923/26]
Ken O'Flynn Written 26 May 2026 · to Health
1223. Deputy Ken O'Flynn asked the Minister for Health if the HSE has assessed the clinical impact of reimbursement delays for patients with progressive neurological conditions where irreversible deterioration may occur during the assessment process. [39068/26]
Ken O'Flynn Written 26 May 2026 · to Health
1224. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains any target timeframe for completion of reimbursement assessments relating to treatments for progressive neurodegenerative diseases. [39069/26]
Ken O'Flynn Written 26 May 2026 · to Health
1252. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or expenditure-control process has examined referral concentration patterns, repeat provider usage, or high-cost treatment clustering under the treatment abroad scheme since 2020. [39145/26]
Ken O'Flynn Written 26 May 2026 · to Health
1288. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme for procedures not currently available in Ireland. [39190/26]
Ken O'Flynn Written 26 May 2026 · to Health
1290. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records clinical outcomes, complication rates or patient satisfaction data in respect of procedures funded under the treatment abroad scheme. [39192/26]
Ken O'Flynn Written 26 May 2026 · to Health
1293. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audit specifically examining value-for-money, expenditure controls or financial governance under the treatment abroad scheme since 2020. [39195/26]
Ken O'Flynn Written 26 May 2026 · to Health
1294. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains data comparing the cost of treatments funded abroad under the treatment abroad scheme against estimated equivalent domestic treatment costs. [39196/26]
Ken O'Flynn Written 26 May 2026 · to Health
1297. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central register of adverse clinical outcomes, complications, revision procedures, hospital readmissions or patient safety incidents arising from treatments funded under the treatment abroad scheme.; and if she will make a statement on the matter. [39199/26]
Ken O'Flynn Written 26 May 2026 · to Health
1298. Deputy Ken O'Flynn asked the Minister for Health whether the HSE receives any routine post-treatment clinical outcome reports from overseas providers in respect of procedures funded under the treatment abroad scheme. [39200/26]
Ken O'Flynn Written 26 May 2026 · to Health
1300. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any review of long-term patient outcomes associated with procedures funded under the treatment abroad scheme since 2020. [39202/26]
Ken O'Flynn Written 26 May 2026 · to Health
1304. Deputy Ken O'Flynn asked the Minister for Health the number of complaints, adverse incident reports, legal claims or clinical governance concerns associated with procedures funded under the treatment abroad scheme since 2020. [39206/26]
Ken O'Flynn Written 26 May 2026 · to Health
1305. Deputy Ken O'Flynn asked the Minister for Health whether the Department has sought legal advice regarding governance and duty-of-care obligations arising from State-funded overseas medical procedures where no structured outcomes monitoring system exists. [39207/26]
Ken O'Flynn Written 26 May 2026 · to Health
1310. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has ever examined category-specific overseas treatment expenditure under the treatment abroad scheme; and if so, to provide details. [39213/26]
Ken O'Flynn Written 26 May 2026 · to Health
1312. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework exists governing referrals for overseas gender affirmation surgeries funded through the treatment abroad scheme. [39215/26]
Ken O'Flynn Written 26 May 2026 · to Health
1314. Deputy Ken O'Flynn asked the Minister for Health whether any post-treatment outcome monitoring or follow-up governance arrangements exist for persons funded for overseas gender affirmation surgeries under the treatment abroad scheme. [39217/26]